Effects of Hydroxychloroquine Treatment on QT Interval
Viral Infections, Non-HIV
Related content
Viral Infections, Non-HIV
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
J Interv Card Electrophysiol.
C Hsia B, Greige N, A Quiroz J, S Khokhar A, Daily J, Di Biase L, J Ferrick K, D Fisher J, Krumerman A
doi: 10.1007/s10840-020-00822-x.
Viral Infections, Non-HIV
Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
J Am Heart Assoc.
Ramireddy A, Chugh H, Reinier K, Ebinger J, Park E, Thompson M, Cingolani E, Cheng S, Marban E, Albert CM, Chugh SS
doi: 10.1161/JAHA.120.017144.
Pain Relief
Side effects can enhance treatment response through expectancy effects: an experimental analgesic randomized controlled trial
Pain.
Berna C, Kirsch I, Zion SR, Lee YC, Jensen KB, Sadler P, Kaptchuk TJ, Edwards RR
doi: 10.1097/
Back PainChronic Pain
Is non-pharmacological treatment an effective option for chronic low back pain?
Ondrejkovicova A, Petrovics G, Svitkova K, Balogh V
Viral Infections, Non-HIV
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review
Ann Intern Med.
Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White CM
doi: 10.7326/M20-2496.
Meningitis
Inhibition of DAMP signaling as an effective adjunctive treatment strategy in pneumococcal meningitis
J Neuroinflammation.
Masouris I, Klein M, Dyckhoff S, Angele B, Pfister HW, Koedel U
doi: 10.1186/s12974-017-0989-0.
Viral Infections, Non-HIV
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
JAMA.
Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, Weinberg P, Kirkwood J, Muse A, DeHovitz J, Blog DS, Hutton B, Holtgrave DR, Zucker HA
doi: 10.1001/jama.2020.8630.
COMMENTED
Further Publications Pain
What mediates treatment effects in a pre-surgery physiotherapy treatment in surgical candidates with degenerative lumbar spine disorders? A mediation and conditional process analysis of the PREPARE randomized controlled trial
★ 3
Recommended and commented by
Dr Roland Schreiber, Faculty Member
Clin J Pain
Fors M, Öberg B, Lindbäck Y, Enthoven P, Abbott A
doi: 10.1097/AJP.0000000000000901
Further Publications Infectiology
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial
Lancet Infect Dis
Dooley KE, Rosenkranz SL, Conradie F, Moran L, Hafner R, von Groote-Bidlingmaier F, Lama JR, Shenje J, De Los Rios J, Comins K, Morganroth J, Diacon AH, Cramer YS, Donahue K, Maartens G, AIDS Clinical Trials Group (ACTG) A5343 DELIBERATE Study Team.
doi: 10.1016/S1473-3099(20)30770-2